期刊文献+

MHCⅡ类反式激活因子基因的克隆、鉴定及初步功能测定 被引量:5

Cloning, identification and preliminary function test of CⅡTA gene
原文传递
导出
摘要 目的 克隆MHCⅡ类反式激活因子 (classⅡtransactivator,CⅡTA)基因并进行初步功能测试 ,为CⅡTA的应用研究奠定基础。方法 RT PCR扩增CⅡTA基因 ,将其克隆到pGEM T载体上并进行酶切和测序鉴定 ;用EcoRⅠ、XhoⅠ将CⅡTA定向克隆到表达载体pcDNA3上 ,用脂质体转染法将pcDNA3/CⅡTA转入HeLa细胞 ;流式细胞术观察细胞表面HLA DR/DQ的表达变化。结果 成功克隆CⅡTA基因 ,CⅡTA基因的转入使HeLa细胞表面表达HLA DR/DQ分子。结论 转入CⅡTA能使HeLa细胞表面表达MHCⅡ类分子表达 ,CⅡTA参与调控MHCⅡ类基因的转录和表达。 Objective Molecular cloning of CⅡTA (classⅡ transactivator) gene and analysis of its function preliminary. Methods CⅡTA gene obtained by RT-PCR was cloned into pGEM-T/pcDNA3 plasmid. Restriction endonuclease and sequence analysis were used to identify the CⅡTA gene. Flow cytometry was used to test the expression of HLA-DR/DQ in HeLa cells transfected by pcDNA3/CⅡTA construction. Results CⅡTA gene clone was obtained and the expression of HLA-DR/DQ in HeLa cells was induced by transfection of CⅡTA gene. Conclusion Transfection of CⅡTA enhanced the expression of MHC class Ⅱ molecules. CⅡTA may play an important role in the transcription and expression of MHC class Ⅱgenes.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2001年第3期241-243,共3页 Chinese Journal of Microbiology and Immunology
基金 上海市科学技术发展基金重点项目! (990 2 1) 福建省自然科学基金资助项目! (2 0 0 0C0 0 1) 福建省教委青年科研基金资助项目! (99
关键词 Ⅱ类反式激活蛋白 基因克隆 MHC HELA细胞 CⅡTA gene Gene cloning MHC HeLa cell
  • 相关文献

参考文献3

  • 1Yun S,Trans plant,1998年,66卷,103页
  • 2Martin B K,Immunity,1997年,6卷,591页
  • 3Chang C H,J Exp Med,1995年,181卷,765页

同被引文献19

  • 1谢晋 周光炎.异种器官移植与免疫排斥[J].国内外医科学进展(年刊),1998,:86-86.
  • 2Nagata Y, Ono S, Matsuo M, et al. Differential presentation of asoluble exogenous tumor antigen, NY-ESO-1, by distinct human dendriticcell populations[J]. Proc Natl Acad Sci USA, 2002, 99(16): 10629-10634.
  • 3Dmitry I, Gabrilouich I, Frank C, et al. Dendritic cells in antitumorimmune responses[J]. Cellular Immunol, 1996, 170(1): 101-110.
  • 4Morris A, Spangler WE, Boss JM. Methylation of class Ⅱ transactivatorpromoter Ⅳ: A novel mechanism of MHC class Ⅱ gene control[J]. J Immunol,2000, 164: 4143-4149.
  • 5Chang CH, Flavell RA. Class Ⅱ transactivator regulates the expressionof multiple genes involved in antigen presentation[J]. J Exp Med, 1995,181: 765-767.
  • 6Inaba K, Inaba M, Romani N, et al. Generation of large number ofdendritic cells from mouse bone marrow culture supplemented withgranulocyte/macrophage colony-stimulating factor[J]. J Exp Med, 1992,176(6): 1693-1702.
  • 7Porgador A, Synder D, Gilboa E, et al. Induction of antitumor immunityusing bone marrow-regulated dendritic cells[J]. J Immunol, 1996, 156(8):2918-2926.
  • 8Tatsumi T, Takehara T, Kanto T, et al. Adminstration of interleukin-12enhances the therapeutic efficacy of the dendritic cell-based tumorvaccines in mouse hepatocellular carcinoma[J]. Cancer Research, 2001, 61:7563-7567.
  • 9Steimle V, Otten LA, Zufferey M, et al. Complementation cloning of an MHC class Ⅱ transactivator mutated in hereditary MHC class Ⅱ deficiency (bare lymphocyte syndrome)[J]. Cell, 1993, 75: 135-146.
  • 10Chin KC, Li G, Ting JPY. Activation and transdominant suppression of MHCclass Ⅱ and HLA-DMB promoters by a series of C-terminal class Ⅱ transactivator deletion mutants[J]. J Immunol, 1997, 159: 2789-2794.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部